3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Lymphoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia
4
Recurrence
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Burkitt Lymphoma
3
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphohistiocytosis, Hemophagocytic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Epstein-Barr Virus Infections
2
Dendritic Cell Sarcoma, Interdigitating
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Sezary Syndrome
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pneumonia, Pneumocystis
1
Pneumonia
1
Neuroma
1
Interventions
Ursodeoxycholic Acid
1
Steroids
1
Spermine Synthase
1
Prednisone
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Liquid Biopsy
1
Clinical Protocols
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hepatitis
×
Methylprednisolone
×
Clear all
NCT04810156
2022-12-14
I-HEP
Herlev Hospital
Phase 2
Unknown
60 enrolled